Background. There are several studies that show a good genotype-phenotype correlation in congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD). However, there is well-documented evidence of inconsistency in some cases. Objectives. To determine if there is a correlation between the identified mutations and the clinical manifestations of 21OHD in the Cuban population. Methods. A cross-sectional descriptive study of all patients referred for a molecular diagnosis of 21OHD in Cuba from January 2000 to December 2018. The clinical manifestations of each patient were identified and classified according to the phenotype. The CYP21A2 gene was analyzed for the presence of 5 point mutations involved in the pathogenesis of 21OHD (intron 2, deletion of 8bp, I172N, P30L, and Q318X); correlation was sought between the phenotypic characteristics and the frequencies of point mutations in the patients using the Spearman test. Results. A total of 55 patients underwent direct analysis of the CYP21A2 gene in order to determine the presence of the 5 point mutations. Point mutations were identified in 31 patients, which corresponded to 56. A statistically significant genotype-phenotype correlation was found. Conclusions. The correlation between the detected molecular defect and the clinical expression of 21OHD was reasonable in the Cuban population, which could allow phenotypic predictions to be made from the genotype.
10 July 2024 in Salud, Ciencia y Tecnología - Serie de Conferencias
Introduction: Fucosidosis is a rare lysosomal storage disease, of which in Cuba, patients have been reported only in Holguín province.Objective: to characterize the epidemiological and genetic-population behavior of fucosidosis in Holguín province.Method: A case series study was carried out, whose universe and sample included all families with patients with fucosidosis, diagnosed between 1985 and 2023. Birth prevalence, mortality rate, attributable mortality, and consanguinity rate were calculated. Gene and genotypic frequencies were estimated from the prevalence. A Hardy-Weinberg test for the analysis of gene equilibrium at the FUCA 1 locus was applied to the results of the genotypic characterization for the Q427X mutation.Results: 19 patients were diagnosed, belonging to 13 families, which represented a birth prevalence of 3.28 x 105 live births. The case fatality and parental consanguinity rates were 0.84 and 0.53 respectively. The estimated frequencies of the recessive allele and the heterozygous genotype were 0.0057271 and 0.0113887, respectively, so approximately 11,660 people in the population of the Holguín province at the end of 2023 must have been carriers. The existence of gene equilibrium for the FUCA1 locus in the population genotypically characterized for the Q427X mutation suggests that the affected families have remained in the original region, and systematic and stochastic factors that alter gene frequencies, including the existence of gene flow, have not occurred since the apparition of the disease due to a founder effect. The mutation rate of the gene must have remained constant according to the selection coefficient at the locus, corresponding to a lethal disease whose fitness is zero.Conclusions: The prevalence of fucosidosis in Holguín province is one of the highest worldwide and is the result of the combination of the founder effect due to genetic drift of the Q427X mutation, with parental consanguinity and genetic isolation due to socioeconomic causes
Background: Xeroderma pigmentosum is a rare disease; however, it is important to be aware of it and differentiate it in current clinical practice due to its significant clinical heterogeneity. It can range from mild to moderate sensitivity to ultraviolet radiation to extreme photosensitivity and skin cancer at an early age. Objective: To describe the biochemical markers that allow the exclusion of the diagnosis of xeroderma pigmentosum in patients with suggestive clinical presentation Method: Cross-sectional descriptive study that included 12 Cuban patients with a presumptive diagnosis of xeroderma pigmentosum, established by a multidisciplinary national medical commission. They presented with photodamage of varying intensity, with signs of chronic actinic damage and/or premalignant lesions or skin cancer. A clinical-biochemical algorithm was applied for disease diagnosis: DNA repair capacity with ultraviolet C radiation was evaluated using alkaline comet assay, and eta polymerase expression was determined using Western blot assay. Blood lymphocytes were used. Key results: DNA repair capacity was normal in all patients (52.4% to 131.7%), indicating a competent repair phenotype. The protein band observed in the Western blot showed normal expression of eta polymerase. Consequently, the diagnosis of the disease was excluded. The variability observed in repair combined with the clinical characteristics suggested a differentiated analysis in patients with 50% to 60% repair rates. Conclusion: The normal biochemical markers analyzed allowed the exclusion of xeroderma pigmentosum diagnosis in a group of patients with signs of chronic actinic damage, premalignant lesion or skin cancer.
8 May 2023 in Salud, Ciencia y Tecnología - Serie de Conferencias
Introduction: Prader-Willi syndrome, caused by the absence of expression of the paternal 15q11-13 region, is the first imprinting defect disorder described in humans. With an incidence of 1 in 10000-15000, its clinical phenotype characterized by hypotonia, obesity and hypogonadism overlaps with a group of genetically heterogeneous syndromes defined as Prader Willi-like syndrome or Prader Willi like. In this group, deletion 1p36, deletion 2p, deletion 6q, among others, are reported. Objective: to identify chromosomal aberrations in the conventional karyotype of patients with suspected Prader Willi syndrome. Methods: we analyzed the results of conventional karyotyping in lymphocytes, FISH molecular studies and methylation-based polymerase chain reaction of 112 patients referred during the period 2010-2019 for suspected Prader Willi syndrome. Results: Prader Willi syndrome was confirmed in 45,5 % of the patients. Chromosomal aberrations outside the 15q11.13 region were found in 5,3 % of cases including: chromosome 22 ring, trisomy 21 mosaic, 6p admixture, reverse sex and chromosome 21 inversion. Conclusions: In patients with Prader Willi phenotype, clinical suspicion is often not confirmed by molecular studies. Conventional karyotyping may reveal Prader Willi-like syndrome due to aberrations at sites involved in neuroendocrine control outside the 15q11.13 region. In these cases chromosomal diagnosis is essential for more effective prevention strategies as part of genetic counseling for patients and families.